Matches in Wikidata for { <http://www.wikidata.org/entity/Q66074655> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q66074655 description "assaig clínic" @default.
- Q66074655 description "clinical trial" @default.
- Q66074655 description "clinical trial" @default.
- Q66074655 description "clinical trial" @default.
- Q66074655 description "clinical trial" @default.
- Q66074655 description "ensaio clínico" @default.
- Q66074655 description "ensayo clínico" @default.
- Q66074655 description "ensayu clínicu" @default.
- Q66074655 description "essai clinique" @default.
- Q66074655 description "klinisch onderzoek" @default.
- Q66074655 description "клінічне випробування" @default.
- Q66074655 name "Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction" @default.
- Q66074655 name "Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction" @default.
- Q66074655 type Item @default.
- Q66074655 label "Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction" @default.
- Q66074655 label "Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction" @default.
- Q66074655 prefLabel "Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction" @default.
- Q66074655 prefLabel "Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction" @default.
- Q66074655 P1050 Q66074655-E83F9C2A-0170-4555-A1D8-468F47136E5A @default.
- Q66074655 P1132 Q66074655-2BAD3B5F-EEC0-4549-9FDD-928A42936E38 @default.
- Q66074655 P1476 Q66074655-48279222-D26C-4348-89D6-480FD170E440 @default.
- Q66074655 P1813 Q66074655-B46EBB96-733A-48F1-97FA-9AD824FF264A @default.
- Q66074655 P2899 Q66074655-D169C691-7752-449B-80A1-68FB8AAE4978 @default.
- Q66074655 P3098 Q66074655-5FDB1987-C7A0-4269-826F-DBFA348E434E @default.
- Q66074655 P31 Q66074655-1FFBA334-E839-46C0-A8D8-174F8BD55E24 @default.
- Q66074655 P4135 Q66074655-5731EE8B-AF4E-4566-AA79-08F918B28DC5 @default.
- Q66074655 P580 Q66074655-C3C217DC-35FB-4B17-90C2-CA1DDBBEC019 @default.
- Q66074655 P582 Q66074655-E7A96462-459D-4FDD-87DE-82AF200BDAA1 @default.
- Q66074655 P6099 Q66074655-4917608B-84DF-44B1-A9B9-B790E1BAEA86 @default.
- Q66074655 P6099 Q66074655-D98C2F2D-6A70-453C-83D5-C1A3F06BAB54 @default.
- Q66074655 P8363 Q66074655-5472A9DD-EFAB-4BD8-96A5-EEFDB80966E8 @default.
- Q66074655 P1050 Q188151 @default.
- Q66074655 P1132 "+320" @default.
- Q66074655 P1476 "A Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and Efficacy of Rejuveinix in Combination With Standard Interventional Therapy for Critical Limb Ischemia Patients" @default.
- Q66074655 P1813 "RESTORE" @default.
- Q66074655 P2899 "+19" @default.
- Q66074655 P3098 "NCT03041259" @default.
- Q66074655 P31 Q30612 @default.
- Q66074655 P4135 "+90" @default.
- Q66074655 P580 "2020-01-01T00:00:00Z" @default.
- Q66074655 P582 "2022-01-01T00:00:00Z" @default.
- Q66074655 P6099 Q42824440 @default.
- Q66074655 P6099 Q5452194 @default.
- Q66074655 P8363 Q78089383 @default.